首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >The relationship between kidney function and long-term graft survival after kidney transplant.
【24h】

The relationship between kidney function and long-term graft survival after kidney transplant.

机译:肾移植后肾脏功能与长期移植物存活之间的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Whether chronic kidney disease (CKD) staging provides a useful framework for predicting outcomes after kidney transplant is unclear. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: We used data from the Patient Outcomes in Renal Transplantation (PORT) Study, including 13,671 transplants from 12 centers during 10 years of follow-up. PREDICTOR: Estimated glomerular filtration rate (eGFR; in milliliters per minute per 1.73 m(2)) at 12 months posttransplant. OUTCOMES: All-cause graft failure (a composite end point consisting of return to dialysis therapy, pre-emptive retransplant, or death with function), death-censored graft failure, and death with a functioning graft. MEASUREMENTS: The relationship between 12-month eGFR and subsequent graft outcomes through 10 years posttransplant was assessed using Cox proportional hazards analyses. RESULTS: Stage 3 included 63% of patients and was subdivided into stages 3a (eGFR, 45-59 mL/min/1.73 m(2); 34%) and 3b (eGFR, 30-44 mL/min/1.73 m(2); 29%). Compared with stage 2 (eGFR, 60-89 mL/min/1.73 m(2); 24%), adjusted Cox proportional HRs for graft failure were 1.12 (95% CI, 1.01-1.24; P = 0.04) for stage 3a, 1.50 (95% CI, 1.35-1.66; P < 0.001) for stage 3b, 2.86 (95% CI, 2.53-3.22; P < 0.001) for stage 4 (eGFR, 15-29 mL/min/1.73 m(2); 9%), and 13.2 (95% CI, 10.7-16.4; P < 0.001) for stage 5 (eGFR <15 mL/min/1.73 m(2); 1%). For stage 1 (eGFR >/= 90 mL/min/1.73 m(2); 3%), risk of graft failure was increased (1.41 [95% CI, 1.13-1.75]; P < 0.001), likely due to serum creatinine associations independent of kidney function. Similar associations were seen between CKD stages and mortality. LIMITATIONS: Retrospective study; lack of gold-standard measurements of true GFR; lack of measures of comorbidity, inflammation, muscle mass, proteinuria, and other noncreatinine markers of eGFR. CONCLUSIONS: CKD stages validated in the general population provide a useful framework for predicting outcomes after kidney transplant.
机译:背景:慢性肾脏疾病(CKD)分期是否为预测肾移植后的预后提供了有用的框架尚不清楚。研究设计:回顾性队列研究。地点与参与者:我们使用了来自肾脏移植(PORT)研究的患者结果数据,包括在10年的随访期间从12个中心进行的13671例移植。预测:移植后12个月的估计肾小球滤过率(eGFR;以每分钟1.73 m(2)毫升为单位)。结果:全因移植失败(复合终点包括恢复透析治疗,先发性再移植或功能死亡),以死亡检查的移植失败和因功能正常的移植死亡。测量:使用Cox比例风险分析评估了12个月eGFR与移植后10年后移植物预后之间的关系。结果:第3阶段包括63%的患者,分为3a(eGFR,45-59 mL / min / 1.73 m(2); 34%)和3b(eGFR,30-44 mL / min / 1.73 m(2) ); 29%)。与阶段2(eGFR,60-89 mL / min / 1.73 m(2); 24%)相比,阶段3a的校正后的Cox比例HRs为1.12(95%CI,1.01-1.24; P = 0.04),对于阶段3b为1.50(95%CI,1.35-1.66; P <0.001),对于阶段4b(eGFR,15-29 mL / min / 1.73 m(2)为2.86(95%CI,2.53-3.22; P <0.001) ; 9%)和13.2(95%CI,10.7-16.4; P <0.001)用于阶段5(eGFR <15 mL / min / 1.73 m(2); 1%)。对于第1阶段(eGFR> / = 90 mL / min / 1.73 m(2); 3%),移植失败的风险增加(1.41 [95%CI,1.13-1.75]; P <0.001),可能是由于血清肌酐协会独立于肾脏功能。 CKD分期与死亡率之间存在相似的关联。局限性:回顾性研究;缺乏真实GFR的金标准测量;缺乏合并症,炎症,肌肉质量,蛋白尿和eGFR的其他非肌酐标记物的测量方法。结论:在一般人群中验证的CKD阶段为预测肾移植后的结果提供了有用的框架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号